Cargando…
A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India
INTRODUCTION: Deficiency of factor VIII (Hemophilia A), factor IX (Hemophilia B) and Von Willebrand's factor are the most frequent coagulation defects. The incidence of inhibitors in patients of factor VIII deficiency is varies in different regions of India. AIM: To determine the prevalence, cl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691464/ https://www.ncbi.nlm.nih.gov/pubmed/31463277 http://dx.doi.org/10.4103/jfmpc.jfmpc_316_19 |
_version_ | 1783443388881698816 |
---|---|
author | Kumar, Sandip Sinha, Sachidanand Bharti, Anju Meena, Lalit P. Gupta, Vineeta Shukla, Jyoti |
author_facet | Kumar, Sandip Sinha, Sachidanand Bharti, Anju Meena, Lalit P. Gupta, Vineeta Shukla, Jyoti |
author_sort | Kumar, Sandip |
collection | PubMed |
description | INTRODUCTION: Deficiency of factor VIII (Hemophilia A), factor IX (Hemophilia B) and Von Willebrand's factor are the most frequent coagulation defects. The incidence of inhibitors in patients of factor VIII deficiency is varies in different regions of India. AIM: To determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of Hemophilia in north eastern part of India. METHODS: Selected patients were under went for complete Blood Count (CBC), General Blood Picture (GBP), Prothrombin time (PT), Activated partial thromboplastin time (APTT), Thrombin time, Correction experiment to know the specific factor deficiency or inhibitors present by Normal Plasma, Normal aged serum, Al(OH)(3) adsorbed plasma. RESULTS: 92 patients diagnosed as suffering with Hemophilia A or B were included in study. The age of patients ranged from 2.5 month to 53 years. Out of 92, seventy nine (85.87%) were Haemophilia A and thirteen were (14.13%) Hemophilia B patients. 3.50% (2/55) cases of treated Hemophilia A patient develop inhibitor. CONCLUSION: The prevalence of hemophilia and incidence of inhibitors in these patients is varies in different regions of India. This variation may be due to the type of product used as treatment, intensity of treatment or the genetic characteristics of the patients. |
format | Online Article Text |
id | pubmed-6691464 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-66914642019-08-28 A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India Kumar, Sandip Sinha, Sachidanand Bharti, Anju Meena, Lalit P. Gupta, Vineeta Shukla, Jyoti J Family Med Prim Care Original Article INTRODUCTION: Deficiency of factor VIII (Hemophilia A), factor IX (Hemophilia B) and Von Willebrand's factor are the most frequent coagulation defects. The incidence of inhibitors in patients of factor VIII deficiency is varies in different regions of India. AIM: To determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of Hemophilia in north eastern part of India. METHODS: Selected patients were under went for complete Blood Count (CBC), General Blood Picture (GBP), Prothrombin time (PT), Activated partial thromboplastin time (APTT), Thrombin time, Correction experiment to know the specific factor deficiency or inhibitors present by Normal Plasma, Normal aged serum, Al(OH)(3) adsorbed plasma. RESULTS: 92 patients diagnosed as suffering with Hemophilia A or B were included in study. The age of patients ranged from 2.5 month to 53 years. Out of 92, seventy nine (85.87%) were Haemophilia A and thirteen were (14.13%) Hemophilia B patients. 3.50% (2/55) cases of treated Hemophilia A patient develop inhibitor. CONCLUSION: The prevalence of hemophilia and incidence of inhibitors in these patients is varies in different regions of India. This variation may be due to the type of product used as treatment, intensity of treatment or the genetic characteristics of the patients. Wolters Kluwer - Medknow 2019-07 /pmc/articles/PMC6691464/ /pubmed/31463277 http://dx.doi.org/10.4103/jfmpc.jfmpc_316_19 Text en Copyright: © 2019 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kumar, Sandip Sinha, Sachidanand Bharti, Anju Meena, Lalit P. Gupta, Vineeta Shukla, Jyoti A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India |
title | A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India |
title_full | A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India |
title_fullStr | A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India |
title_full_unstemmed | A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India |
title_short | A study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in North Eastern part of India |
title_sort | study to determine the prevalence, clinical profile and incidence of formation of inhibitors in patients of hemophilia in north eastern part of india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691464/ https://www.ncbi.nlm.nih.gov/pubmed/31463277 http://dx.doi.org/10.4103/jfmpc.jfmpc_316_19 |
work_keys_str_mv | AT kumarsandip astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT sinhasachidanand astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT bhartianju astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT meenalalitp astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT guptavineeta astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT shuklajyoti astudytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT kumarsandip studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT sinhasachidanand studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT bhartianju studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT meenalalitp studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT guptavineeta studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia AT shuklajyoti studytodeterminetheprevalenceclinicalprofileandincidenceofformationofinhibitorsinpatientsofhemophiliainnortheasternpartofindia |